DGAP-News 697 0 Kommentare ORYX to Present at Sachs European Life Science CEO Forum and Exhibition

DGAP-News: ORYX GmbH & Co. KG / Key word(s): Conference
ORYX to Present at Sachs European Life Science CEO Forum and
Exhibition

03.03.2015 / 11:30

---------------------------------------------------------------------

Press Release

ORYX to Present at Sachs European Life Science CEO Forum and Exhibition

Munich (Germany), March 03, 2015: ORYX, a translational medicine company
focused on oncolytic virotherapy and cancer vaccines, announced today its
participation at Sachs European Life Science CEO Forum and Exhibition
taking place in Zurich, Switzerland, on March 3-4, 2015.

Dr. Bernard Huber, CEO and Founder of ORYX, will present at 11:15 am (CET)
on March 4, 2015 in Room Panorama C.

At Sachs European Life Science CEO Forum and Exhibition, around 80
companies from Europe and the US will present to leading investors, pharma
companies and scientific thought leaders.

About ORYX:
ORYX is a privately held Munich based biotech company. ORYX develops three
highly innovative drug candidates for the treatment of cancer, originating
from leading research institutions like the German Cancer Research Center
(DKFZ) and the University of Heidelberg. The ORYX clinical development
portfolio consists of an oncolytic virus and two therapeutic cancer
vaccines. ORYX holds exclusive, world-wide licenses for all its development
projects. For more information please visit: www.oryx-medicine.com

For further information, please contact:



Dr. Bernard Huber
Chief Executive Officer
ORYX GmbH & Co. KG
Phone: +49-8106-21-311-0
Email: info@oryx-medicine.com

Business Development                     PR/IR contact
Dr. Dr. Sven Rohmann                     Katja Arnold (CIRO)
Phone: +49-8106-21-311-0                 Executive Director MC Services AG
Mobile: +41-7957-78895                   Phone: +49-89-210-228-40
Email: info@oryx-medicine.com            Email: katja.arnold@mc-services.eu

---------------------------------------------------------------------

03.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------

329053 03.03.2015